Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Shenzhen - Delayed Quote CNY

Shandong Fengyuan Chemical Co., Ltd. (002805.SZ)

Compare
10.85
+0.35
+(3.33%)
At close: 3:04:54 PM GMT+8
Loading Chart for 002805.SZ
  • Previous Close 10.50
  • Open 11.66
  • Bid 10.84 x --
  • Ask 10.85 x --
  • Day's Range 10.62 - 10.97
  • 52 Week Range 8.92 - 18.22
  • Volume 6,215,860
  • Avg. Volume 8,825,566
  • Market Cap (intraday) 3.039B
  • Beta (5Y Monthly) -0.01
  • PE Ratio (TTM) --
  • EPS (TTM) -1.31
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date May 26, 2023
  • 1y Target Est --

Shandong Fengyuan Chemical Co., Ltd. engages in the research and development, production, and sale of industrial oxalic acid, refined oxalic acid, and oxalic acid derivatives in China and internationally. The company provides potassium tetroxalate, potassium dioxalate, sodium nitrate, and lithium iron phosphate products. Its products are mainly used in pharmaceutical, rare earth, fine chemical, daily chemicals, textile printing and dyeing, and other industries, as well as biopharmaceutical, new energy vehicles, energy conservation and environmental protection, and various other fields. Shandong Fengyuan Chemical Co., Ltd. was founded in 2000 and is based in Zaozhuang, China.

www.fengyuanhuaxue.com

716

Full Time Employees

December 31

Fiscal Year Ends

Chemicals

Industry

Recent News: 002805.SZ

View More

Performance Overview: 002805.SZ

Trailing total returns as of 4/10/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

002805.SZ
8.82%
SSE Composite Index (000001.SS)
3.82%

1-Year Return

002805.SZ
27.91%
SSE Composite Index (000001.SS)
6.48%

3-Year Return

002805.SZ
47.83%
SSE Composite Index (000001.SS)
0.87%

5-Year Return

002805.SZ
26.41%
SSE Composite Index (000001.SS)
15.27%

Compare To: 002805.SZ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 002805.SZ

View More

Valuation Measures

Annual
As of 4/9/2025
  • Market Cap

    2.94B

  • Enterprise Value

    4.39B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.07

  • Price/Book (mrq)

    1.52

  • Enterprise Value/Revenue

    3.06

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -25.69%

  • Return on Assets (ttm)

    -5.52%

  • Return on Equity (ttm)

    -15.37%

  • Revenue (ttm)

    1.44B

  • Net Income Avi to Common (ttm)

    -368.87M

  • Diluted EPS (ttm)

    -1.31

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    425.02M

  • Total Debt/Equity (mrq)

    72.46%

  • Levered Free Cash Flow (ttm)

    903.46M

Research Analysis: 002805.SZ

View More

Company Insights: 002805.SZ

Research Reports: 002805.SZ

View More

People Also Watch